CXCL6 and hepatocellular carcinoma: Moreover, studies have suggested that CXCL6 can be regulated by specific cell signaling pathways, such as the HIF-1α pathway in hepatocellular carcinoma and the IL4 pathway through the JAK-STAT mechanism in atopic dermatitis (48, 49).